Identification of herpesvirus sylvilagus-induced polypeptides in productively infected cellsPATICK, A. K; HINZE, H. C.Journal of virology. 1984, Vol 52, Num 3, pp 976-980, issn 0022-538XArticle

Protease inhibitors as antiviral agentsPATICK, A. K; POTTS, K. E.Clinical microbiology reviews (Print). 1998, Vol 11, Num 4, pp 614-627, issn 0893-8512Article

Abrogation of resistance to Theiler's virus-induced demyelination in C57BL mice by total body irradiationRODRIGUEZ, M; PATICK, A. K; PEASE, L. R et al.Journal of neuroimmunology. 1990, Vol 26, Num 3, pp 189-199, issn 0165-5728Article

Characterization of herpesvirus sylvilagus glycoproteins released into the culture medium of infected cells: antisera to gp13 and gp32 neutralize viral infectivity in vitro and identify antigens on plasma membranes of infected cellsPATICK, A. K; HINZE, H. C.Journal of virology. 1987, Vol 61, Num 11, pp 3580-3588, issn 0022-538XArticle

Activities of the human immunodeficiency virus type 1 (HIV-1) protease inhibitor nelfinavir mesylate in combination with reverse transcriptase and protease inhibitors against acute HIV-1 infection in vitroPATICK, A. K; BORITZKI, T. J; BLOOM, L. A et al.Antimicrobial agents and chemotherapy. 1997, Vol 41, Num 10, pp 2159-2164, issn 0066-4804Article

Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from patients treated with the protease inhibitor nelfinavirPATICK, A. K; DURAN, M; CAO, Y et al.Antimicrobial agents and chemotherapy. 1998, Vol 42, Num 10, pp 2637-2644, issn 0066-4804Article

Design, synthesis, and evaluation of nonpeptidic inhibitors of human rhinovirus 3C proteaseWEBBER, S. E; TIKHE, J; BROWN, E. L et al.Journal of medicinal chemistry (Print). 1996, Vol 39, Num 26, pp 5072-5082, issn 0022-2623Article

Coexpression of class I major histocompatibility antigen and viral RNA in central nervous system of mice infected with Theiler's virus : a model for multiple sclerosisLINDSLEY, M. D; PATICK, A. K; PRAYOONWIWAT, N et al.Mayo Clinic proceedings. 1992, Vol 67, Num 9, pp 829-838, issn 0025-6196Article

Inhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitorZALMAN, L. S; BROTHERS, M. A; DRAGOVICH, P. S et al.Antimicrobial agents and chemotherapy. 2000, Vol 44, Num 5, pp 1236-1241, issn 0066-4804Article

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studiesDRAGOVICH, P. S; WEBBER, S. E; TIKHE, J et al.Journal of medicinal chemistry (Print). 1998, Vol 41, Num 15, pp 2819-2834, issn 0022-2623Article

In Vitro Resistance Study of Rupintrivir, a Novel Inhibitor of Human Rhinovirus 3C ProteaseBINFORD, S. L; WEADY, P. T; MALDONADO, F et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 12, pp 4366-4373, issn 0066-4804, 8 p.Article

Antiviral properties of aminodiol inhibitors against human immunodeficiency virus and proteaseBECHTOLD, C. M; PATICK, A. K; COLONNO, R et al.Antimicrobial agents and chemotherapy. 1995, Vol 39, Num 2, pp 374-379, issn 0066-4804Article

Characterization of a mutant HIV-1 reverse transcriptase resistant to (+)-(5S)-4,5,6,7-tetrahydro-5-methyl-6-(3-methyl-2-butenyl)-imidazo [4,5,1-jk] [1,4] benzodiazepin-2(1H)-thione (TIBO R82150)SAMANTA, H; ROSE, R; PATICK, A. K et al.Antiviral chemistry & chemotherapy. 1994, Vol 5, Num 4, pp 278-281, issn 0956-3202Article

Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitorsDRAGOVICH, P. S; RU ZHOU; MEADOR, J. W et al.Bioorganic & medicinal chemistry letters (Print). 2000, Vol 10, Num 1, pp 45-48, issn 0960-894XArticle

Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus proteasePATICK, A. K; MO, H; WEBBER, S et al.Antimicrobial agents and chemotherapy. 1996, Vol 40, Num 2, pp 292-297, issn 0066-4804Article

Substituted naphthalenones as a new structural class of HIV-1 reverse transcriptase inhibitorsALAM, M; BECHTOLD, C. M; PATICK, A. K et al.Antiviral research. 1993, Vol 22, Num 2-3, pp 131-141, issn 0166-3542Article

Major histocompatibility complex-conferred resistance to Theiler's virus-induced demyelinating disease is inherited as a dominant trait in B10 congenic micePATICK, A. K; PEASE, L. R; DAVID, C. S et al.Journal of virology. 1990, Vol 64, Num 11, pp 5570-5576, issn 0022-538X, 7 p.Article

Biochemical and biophysical characteristics of Rio Bravo virus (Flaviviridae)HENDRICKS, D. A; PATICK, A. K; PETTI, L. M et al.Journal of general virology. 1988, Vol 69, pp 337-347, issn 0022-1317, 2Article

Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitorBINFORD, S. L; MALDONADO, F; BROTHERS, M. A et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 2, pp 619-626, issn 0066-4804, 8 p.Article

Correlation between human immunodeficiency virus genotypic resistance and virologic response in patients receiving nelfinavir monotherapy or nelfinavir with lamivudine and zidovudineATKINSON, B; ISAACSON, J; KNOWLES, M et al.The Journal of infectious diseases. 2000, Vol 182, Num 2, pp 420-427, issn 0022-1899Article

Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acidsDRAGOVICH, P. S; WEBBER, S. E; BROWN, E. L et al.Bioorganic & medicinal chemistry letters (Print). 1999, Vol 9, Num 15, pp 2189-2194, issn 0960-894XArticle

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimeticsDRAGOVICH, P. S; PRINS, T. J; ZHOU, R et al.Journal of medicinal chemistry (Print). 1999, Vol 42, Num 7, pp 1203-1212, issn 0022-2623Article

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 1. Michael acceptor structure-activity studiesDRAGOVICH, P. S; WEBBER, S. E; LITTLEFIELD, E. S et al.Journal of medicinal chemistry (Print). 1998, Vol 41, Num 15, pp 2806-2818, issn 0022-2623Article

Tripeptide aldehyde inhibitors of human rhinovirus 3C protease : Design, synthesis, biological evaluation, and cocrystal structure solution of P₁ glutamine isosteric replacementsWEBBER, S. E; OKANO, K; MEADOR, J. W et al.Journal of medicinal chemistry (Print). 1998, Vol 41, Num 15, pp 2786-2805, issn 0022-2623Article

Role of T cell receptor Vβ genes in Theiler's virus-induced demyelination of miceRODRIGUEZ, M; PATICK, A. K; PEASE, L. R et al.The Journal of immunology (1950). 1992, Vol 148, Num 3, pp 921-927, issn 0022-1767Article